Product Quick Facts
About Bridge Patient Portal
Bridge is an enterprise patient portal and patient engagement solution that provides a superior user experience for healthcare organizations and their patients. It is ideal for organizations seeking to replace their existing EHR system’s patient portal, connect disparate EHR environments with a single patient portal, and/or consolidate costly patient engagement tools with a single patient engagement solution. Bridge truly engages patients with automated electronic communication, and meaningful, multi-platform access to health, financial, and appointment information. With Bridge’s all-in-one patient engagement solution, healthcare organizations can improve patient-physician collaboration, care outcomes, and business profitability.
In an industry where the term “patient engagement” is used to define everything from simple, piecemeal patient communication solutions to antiquated patient portals, Bridge is setting a new standard for patient engagement solutions. Offering a single, mobile-ready solution for secure SMS/email/push notifications, self-scheduling, health information access, patient-provider messaging, and bill pay. Bridge is available as a client-branded HTML-based web application as well as a mobile app, available for iOS and Android. With Bridge’s fully-documented, and free API, customers can easily develop their own interfaces, add-on features and run advanced reports. Month-to-month contracting with scaled pricing based on actual patient registration ensures Bridge and its customers’ goals are aligned towards a highly engaged patient population.
Founded in 2012 and headquartered in Dallas, TX, Bridge is an employee-owned business with installations in over 50 outpatient groups, hospitals, and integrated delivery networks nationwide.
Still not convinced Bridge is right for you? Use our Product Selection Tool to compare other medical software solutions. Have questions? Call one of our unbiased Technology Advisors for a free consultation.
(Last updated on 07/18/2018 by Jonathan Darcy)